These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Increase of human papillomavirus-16 E7-specific T helper type 1 response in peripheral blood of cervical cancer patients after radiotherapy. Delgado FG, Martínez E, Céspedes MA, Bravo MM, Navas MC, Cómbita Rojas AL. Immunology; 2009 Apr; 126(4):523-34. PubMed ID: 18778290 [Abstract] [Full Text] [Related]
29. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. Gunn GR, Zubair A, Peters C, Pan ZK, Wu TC, Paterson Y. J Immunol; 2001 Dec 01; 167(11):6471-9. PubMed ID: 11714814 [Abstract] [Full Text] [Related]
30. Immuno-Stimulating Peptide Derived from HMGB1 is More Effective Than the N-Terminal Domain of Gp96 as an Endogenous Adjuvant for Improvement of Protein Vaccines. Talebi S, Bolhassani A, Azad TM, Arashkia A, Modaresi MH. Protein Pept Lett; 2017 Dec 01; 24(3):190-196. PubMed ID: 28000571 [Abstract] [Full Text] [Related]
31. Tumor regression in mice following vaccination with human papillomavirus E7 recombinant protein in PROVAX. Hariharan K, Braslawsky G, Barnett RS, Berquist LG, Huynh T, Hanna N, Black A. Int J Oncol; 1998 Jun 01; 12(6):1229-35. PubMed ID: 9592179 [Abstract] [Full Text] [Related]
32. SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model. Sharma RK, Srivastava AK, Yolcu ES, MacLeod KJ, Schabowsky RH, Madireddi S, Shirwan H. Vaccine; 2010 Aug 16; 28(36):5794-802. PubMed ID: 20603135 [Abstract] [Full Text] [Related]
35. Immunological protection against HPV16 E7-expressing human esophageal cancer cell challenge by a novel HPV16-E6/E7 fusion protein based-vaccine in a Hu-PBL-SCID mouse model. Lu Y, Zhang Z, Liu Q, Liu B, Song X, Wang M, Zhao X, Zhao Q. Biol Pharm Bull; 2007 Jan 16; 30(1):150-6. PubMed ID: 17202676 [Abstract] [Full Text] [Related]
40. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck. Albers A, Abe K, Hunt J, Wang J, Lopez-Albaitero A, Schaefer C, Gooding W, Whiteside TL, Ferrone S, DeLeo A, Ferris RL. Cancer Res; 2005 Dec 01; 65(23):11146-55. PubMed ID: 16322265 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]